Research and Practice Awards
General Information
The purpose of the CPNP Awards is to recognize excellent investigators presenting abstracts at the CPNP Annual Meeting to be held April 29-May 2, 2012, at the Marriott Tampa Waterside Hotel and Marina in Tampa, Florida.
Awards are available in five different categories (additional details and eligibility requirements are documented in the 2012 CPNP Poster Presenter Handbook):
- Research Trainee Award
- New Investigator Award
- Original Research
- Innovative Practices Award
- Therapeutic Case Report Award
Award Finalists
Research Trainee Award Finalists
Kristen N. Gardner, Student Pharmacist, University of Michigan College of Pharmacy, Ann Arbor, MI
Relationship Between The Fatty Acid Desaturase 2 (FADS2) Gene Variant rs174583 And Lipid Levels In Subjects With Schizophrenia
Caitlin M. Hughes, PharmD, PGY2 Psychiatry Resident, UNC Hospitals, Chapel Hill, NC
Clinical Management of Metabolic Syndrome: Does Mental Illness Impact Care?
Innovative Practices Award Finalists
Thea R. Moore, PharmD, BCPP, Associate Professor, University of South Florida, Tampa, FL
Utilization of Practice Faculty in the Development of Neuro/Psych Geriatric Pharmacy Services in a Health Science Center
Morgan C. Snyder, PharmD, Resident, The University of Texas at Austin College of Pharmacy, Austin, TX
Application of STOPP Criteria in Comparison to Beers Criteria in an Inpatient Psychiatric Facility and Impact on Utilization of Potentially Inappropriate Medications and Adverse Outcomes
Therapeutic Case Report Award Finalists
Jonathan G. Leung, PharmD, BCPP, BCPS, Psychiatric Clinical Pharmacist, Western Psychiatric Institute and Clinic/University of Pittsburgh Medical Center, Pittsburgh, PA
Donepezil as a Precipitating Factor of Mania: A Case Report
Amber Riesselman, PharmD, Assistant Professor, Sullivan University College of Pharmacy, Louisville, KY
"Closing-in" on clozapine dosing: a case warranting therapeutic drug monitoring
Original Research Award Finalists
Alberto Augsten, PharmD, BCPP, Clinical Psychiatric Pharmacy Specialist, Memorial Regional Hospital, Miami, FL
Comparison of psychiatric readmission rates of intramuscular paliperidone palmitate versus oral paliperidone
Douglas L. Boggs, PharmD, BCPP, MS, Clinical Pharmacy Specialist Psychiatry, VA Connecticut Healthcare System, West Haven, CT
Effects of Intravenous Nicotine on Symptomology and Cognition in Schizophrenia




